Common Admission Test (CAT) is one the highly renowned entrance exam for the 2-year MBA/PGDM admission to the 22 IIMs in ...

Jake Fillery is an Editor (Guides) at GameRant and has been helping provide day-one coverage for the latest AAA and live-service games. If there’s someone to guide you through every Call of Duty ...

Jasneet Singh is a writer who finally has a platform to indulge in long rants about small moments on TV and film in overwhelming detail. With a literature background, she is drawn to the narrative ...

Eighth graders can be successful in Algebra 1, new research suggests—they just might need some extra support. The findings come from a study of San Francisco schools, which has had a turbulent history ...

Mezigdomide (a CELMoD) combined with carfilzomib/dexamethasone met the phase 3 primary end point, delivering statistically significant, clinically meaningful PFS ...

CD40 agonist mitazalimab + mFOLFIRINOX (mFFX) in patients with metastatic pancreatic ductal adenocarcinoma (mPDAC): Final efficacy analysis of the OPTIMIZE-1 study. This is an ASCO Meeting Abstract ...

Carotid artery stenting combined with medical therapy demonstrated a significantly lower stroke risk compared to intensive medical therapy alone in patients with severe asymptomatic carotid stenosis ...

SAN FRANCISCO and SUZHOU, China, Nov. 19, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and ...

Add Yahoo as a preferred source to see more of our stories on Google. ChatGPT Study Mode wasn’t built for journalists with math trauma—but it turns out, it’s exactly what I needed. This week, I got a ...

Two-bedders have become one of the most discussed layouts in the property market today, not just because three or four-bedders are now out of reach for many, but also because one-bedders have fallen ...

Low- and middle-income countries face substantial challenges in immunizing against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), including high costs, limited access, and insufficient ...

A phase 2 study of Vigil Neuroscience’s iluzanebart has missed its biomarker and efficacy endpoints, prompting the Sanofi-bound biotech to stop a long-term extension trial of the TREM2 agonist. Sanofi ...